Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 676 to 700 of 1907 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
1119 Failure in gamma-glutamyl carboxylation of glutamine residues on clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)
0 Nov 29, 2016 Nov 29, 2016 None
1120 Under carboxylated clotting factors will not assemble on cell surfaces , Failure to form clot
0 Nov 29, 2016 Nov 29, 2016 None
1121 Hemorrhage , organ dysfunction, hypovolemic shock
0 Nov 29, 2016 Nov 29, 2016 None
1122 Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis
1 Tissue Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1123 Hemorrhage, organ dysfunction, hypovolemic shock, Impaired oxygen delivery to tissue
0 Nov 29, 2016 Nov 29, 2016 None
1124 Hemorrhage , Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
0 Nov 29, 2016 Nov 29, 2016 None
1125 Impaired oxygen and nutrient delivery to tissue, impaired removal of carbon dioxide and other waste products, Hemorrhage, organ dysfunction and hypovolemic shock
0 Nov 29, 2016 Nov 29, 2016 None
1126 Unresolved blood loss, Failure in vascular repair mechanisms
0 Nov 29, 2016 Nov 29, 2016 None
1127 Anemia, Impaired oxygen and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
0 Nov 29, 2016 Nov 29, 2016 None
1128 Unresolved hemorrhage, Failure in vascular repair mechanisms
0 Nov 29, 2016 Nov 29, 2016 None
1129 Unresolved blood loss (hemorrhage), Failure in vascular repair mechanisms
0 Nov 29, 2016 Nov 29, 2016 None
1130 Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)
2 Organ Nov 29, 2016 Sep 16, 2017 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1131 Failure in gamma-glutamyl carboxylation of clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)
4 Molecular Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1132 Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal
3 Cellular Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1133 Hemostasis, Depletion from blood of fully functional carboxylated clotting factors
2 Tissue Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1134 Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
3 Molecular Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1135 Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction
5 Tissue Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1136 Impaired recruitment , Population trajectory
1 Population Nov 29, 2016 Dec 3, 2016 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1137 Under carboxylation of osteocalcin, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone
0 Nov 29, 2016 Nov 29, 2016 None
1138 Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP
2 Molecular Nov 29, 2016 Sep 16, 2017 187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
1139 Increased, water retention in foot
0 Organ Nov 29, 2016 Dec 3, 2016 97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
1140 Delayed, Sexual maturity
0 Individual Nov 29, 2016 Dec 3, 2016 None
1141 Decreased, Reproductive Success
0 Individual Nov 29, 2016 Dec 3, 2016
1142 Increased, valve movement
1 Tissue Nov 29, 2016 Dec 3, 2016
1143 Depletion, energy reserves
0 Individual Nov 29, 2016 Dec 3, 2016 97: 5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline